(Q50971850)

English

Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study.

scientific article published on 24 January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22281433

Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22281433

adverse prognostic factor

1 reference

based on heuristic

inferred from title

renal cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

Alessandro Antonelli

1

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22281433

Nicola Arrighi

2

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22281433

Serena Corti

3

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22281433

Tiziano Zanotelli

4

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22281433

Alberto Cozzoli

5

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22281433

Sergio Cosciani Cunico

6

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22281433

Claudio Simeone

7

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22281433

publication date

24 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22281433

Urologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22281433

31

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22281433

7

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22281433

1310-1315

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22281433

Diabetes mellitus and risk of breast cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.013

7 January 2021

Diabetes mellitus and risk of colorectal cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.013

7 January 2021

Diabetes mellitus and risk of endometrial cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.013

7 January 2021

The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.013

7 January 2021

Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.013

7 January 2021

Diabetes and urothelial cancer risk: the Multiethnic Cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.013

7 January 2021

Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.013

7 January 2021

Diabetes, prediabetes and cancer mortality

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.013

7 January 2021

Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.013

7 January 2021

Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.013

7 January 2021

Multi-institutional validation of a symptom based classification for renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.013

7 January 2021

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.013

7 January 2021

Prognostic significance of morphologic parameters in renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.013

7 January 2021

Active Smoking and the Risk of Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.013

7 January 2021

The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.013

7 January 2021

Renal cell carcinoma in relation to cigarette smoking: Meta-analysis of 24 studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.013

7 January 2021

Obesity, hypertension, and the risk of kidney cancer in men

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.013

7 January 2021

Insulin and insulin-like growth factor signalling in neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.013

7 January 2021

The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.013

7 January 2021

Self-reported diabetes mellitus and risk of mortality from all causes, cardiovascular disease, and cancer in Takayama: a population-based prospective cohort study in Japan

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.013

7 January 2021

Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.013

7 January 2021

Effect of diabetes mellitus on outcomes of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.013

7 January 2021

Type 2 diabetes does not worsen prognosis in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.013

7 January 2021

Identifiers

10.1016/J.UROLONC.2011.12.013

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22281433

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22281433

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50971850&oldid=1517870610"